253 related articles for article (PubMed ID: 37302955)
21. NK/T-cell lymphomas in children.
Lai C; Dunleavy K
Best Pract Res Clin Haematol; 2013 Mar; 26(1):33-41. PubMed ID: 23768639
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma.
Gibson JF; Alpdogan O; Subtil A; Girardi M; Wilson LD; Roberts K; Foss F
J Am Acad Dermatol; 2015 Jun; 72(6):1010-5.e5. PubMed ID: 25981001
[TBL] [Abstract][Full Text] [Related]
23. The aggressive peripheral T-cell lymphomas: 2015.
Armitage JO
Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
[TBL] [Abstract][Full Text] [Related]
24. T cell and NK cell lymphoproliferative disorders.
Greer JP; Kinney MC; Loughran TP
Hematology Am Soc Hematol Educ Program; 2001; ():259-81. PubMed ID: 11722988
[TBL] [Abstract][Full Text] [Related]
25. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
26. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
27. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
[TBL] [Abstract][Full Text] [Related]
28. T-cell lymphomas in a tertiary care center of Mangalore.
Lobo FD; Garg P; Pai RR; Kini H; Prasad K
J Cancer Res Ther; 2020; 16(1):94-97. PubMed ID: 32362615
[TBL] [Abstract][Full Text] [Related]
29. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
[TBL] [Abstract][Full Text] [Related]
30. Molecular etiology of mature T-cell non-Hodgkin's lymphomas.
Evens AM; Gartenhaus RB
Front Biosci; 2003 Jan; 8():d156-75. PubMed ID: 12456315
[TBL] [Abstract][Full Text] [Related]
31. Treatment of T-cell non-Hodgkin's lymphoma.
Evens AM; Gartenhaus RB
Curr Treat Options Oncol; 2004 Aug; 5(4):289-303. PubMed ID: 15233906
[TBL] [Abstract][Full Text] [Related]
32. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression.
Huang HS; Liao CK; Liu TT; You HL; Wang MC; Huang WT
Hum Pathol; 2018 Oct; 80():145-151. PubMed ID: 29885407
[TBL] [Abstract][Full Text] [Related]
33. Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay.
Drieux F; Ruminy P; Abdel-Sater A; Lemonnier F; Viailly PJ; Fataccioli V; Marchand V; Bisig B; Letourneau A; Parrens M; Bossard C; Bruneau J; Dobay P; Veresezan L; Dupuy A; Pujals A; Robe C; Sako N; Copie-Bergman C; Delfau-Larue MH; Picquenot JM; Tilly H; Delarue R; Jardin F; de Leval L; Gaulard P
Haematologica; 2020 Jun; 105(6):1582-1592. PubMed ID: 31488561
[TBL] [Abstract][Full Text] [Related]
34. Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches.
Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830926
[TBL] [Abstract][Full Text] [Related]
35. Surface CD3-negative monomorphic epitheliotropic intestinal T-cell lymphoma.
Domoto H; Araki T; Ogai A; Inukai M; Chen CK; Tomita S; Mukai K; Nakamura N
J Clin Exp Hematop; 2022 Sep; 62(3):169-174. PubMed ID: 35979577
[TBL] [Abstract][Full Text] [Related]
36. Zebras and hen's teeth: recognition and management of rare T and NK lymphomas.
Mehta-Shah N; Horwitz S
Hematology Am Soc Hematol Educ Program; 2015; 2015():545-9. PubMed ID: 26637770
[TBL] [Abstract][Full Text] [Related]
37. Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls.
Jaffe ES; Nicolae A; Pittaluga S
Mod Pathol; 2013 Jan; 26 Suppl 1(Suppl 1):S71-87. PubMed ID: 23281437
[TBL] [Abstract][Full Text] [Related]
38. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.
Rüdiger T; Weisenburger DD; Anderson JR; Armitage JO; Diebold J; MacLennan KA; Nathwani BN; Ullrich F; Müller-Hermelink HK;
Ann Oncol; 2002 Jan; 13(1):140-9. PubMed ID: 11863096
[TBL] [Abstract][Full Text] [Related]
39. Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract.
Kohri M; Tsukasaki K; Akuzawa Y; Tanae K; Takahashi N; Saeki T; Okamura D; Ishikawa M; Maeda T; Kawai N; Matsuda A; Arai E; Arai S; Asou N
Leuk Res; 2020 Apr; 91():106336. PubMed ID: 32151888
[TBL] [Abstract][Full Text] [Related]
40. Approach to nodal-based T-cell lymphomas.
de Leval L
Pathology; 2020 Jan; 52(1):78-99. PubMed ID: 31785821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
